Viridian Therapeutics, Inc. (VRDN)
Viridian Therapeutics Market Cap : 3.505B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.505B |
| November 12, 2026 | 3.460B |
| November 11, 2026 | 3.548B |
| November 10, 2026 | 3.503B |
| November 09, 2026 | 3.427B |
| November 06, 2026 | 3.234B |
| November 05, 2026 | 3.241B |
| November 04, 2026 | 3.298B |
| November 03, 2026 | 2.855B |
| November 02, 2026 | 2.872B |
| October 30, 2026 | 2.794B |
| October 29, 2026 | 2.808B |
| October 28, 2026 | 2.748B |
| October 27, 2026 | 2.728B |
| October 26, 2026 | 2.643B |
| October 23, 2026 | 2.533B |
| October 22, 2026 | 2.584B |
| October 21, 2026 | 2.606B |
| October 20, 2026 | 2.540B |
| October 19, 2026 | 2.355B |
| October 16, 2026 | 2.155B |
| October 15, 2026 | 2.215B |
| October 14, 2026 | 2.081B |
| October 13, 2026 | 2.063B |
| October 12, 2026 | 2.072B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.113B |
| October 08, 2026 | 2.077B |
| October 07, 2026 | 2.070B |
| October 06, 2026 | 2.063B |
| October 05, 2026 | 2.152B |
| October 02, 2026 | 2.197B |
| October 01, 2026 | 2.150B |
| September 30, 2026 | 2.332B |
| September 29, 2026 | 2.264B |
| September 28, 2026 | 2.329B |
| September 25, 2026 | 2.318B |
| September 24, 2026 | 2.340B |
| September 23, 2026 | 2.427B |
| September 22, 2026 | 2.505B |
| September 21, 2026 | 2.444B |
| September 18, 2026 | 2.491B |
| September 17, 2026 | 2.483B |
| September 16, 2026 | 2.541B |
| September 15, 2026 | 2.472B |
| September 14, 2026 | 2.514B |
| September 11, 2026 | 2.405B |
| September 10, 2026 | 2.524B |
| September 09, 2026 | 2.574B |
| September 08, 2026 | 2.624B |
| September 04, 2026 | 2.595B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Travere Therapeutics, Inc. | 4.846B |
| Arrowhead Pharmaceuticals, Inc. | 6.743B |
| Vertex Pharmaceuticals, Inc. | 136.55B |
| TG Therapeutics, Inc. | 9.751B |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
Market Cap Related Metrics
| PS Ratio | 122.58 |
| PEG Ratio | -0.4055 |
| Price to Book Value | 7.261 |
| Price | 30.87 |
| Earnings Yield | -13.53% |
| PEGY Ratio | -0.4055 |